This brand name is authorized in Austria, Brazil, Cyprus, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Japan, Lithuania, Netherlands, New Zealand, Romania, Singapore, Tunisia, Turkey, South Africa
The drug PICOPREP contains a combination of these active pharmaceutical ingredients (APIs):
1
Sodium picosulfate
UNII LR57574HN8 - SODIUM PICOSULFATE
|
Sodium picosulfate is a locally acting laxative from the triarylmethane group, which after bacterial cleavage in the colon, has a dual-action with stimulation of the mucosa of both the large intestine and of the rectum. |
2
Magnesium oxide
UNII 3A3U0GI71G - MAGNESIUM OXIDE
|
Magnesium oxide (MgO), or magnesia, is an empirical formula of MgO and consists of a lattice of Mg2+ ions and O2− ions held together by ionic bonding. |
3
Sodium citrate
UNII XF417D3PSL - ANHYDROUS CITRIC ACID
|
Sodium citrate has no relevant pharmacodynamic activity other than that caused by its alkalinity (e.g. its gastric acid neutralising capacity). Sodium citrate is a non-particulate antacid for use by mouth to prior to general anaesthesia for caesarean section. |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
ATC code | Group title | Classification |
---|---|---|
A06AB58 | Sodium picosulfate, combinations | A Alimentary tract and metabolism → A06 Laxatives → A06A Laxatives → A06AB Contact laxatives |
This drug has been assigned below unique identifiers within the countries it is being marketed:
Country | Identification scheme | Identifier(s) |
---|---|---|
Country: BR | Câmara de Regulação do Mercado de Medicamentos | Identifier(s): 521413110005505 |
Country: EC | Agencia Nacional de Regulación, Control y Vigilancia Sanitaria | Identifier(s): 1379-MEE-0915 |
Country: EE | Ravimiamet | Identifier(s): 1448524, 1500253, 1597495 |
Country: ES | Centro de información online de medicamentos de la AEMPS | Identifier(s): 72279 |
Country: FI | Lääkealan turvallisuus- ja kehittämiskeskus | Identifier(s): 593795 |
Country: FR | Base de données publique des médicaments | Identifier(s): 66769608 |
Country: HK | Department of Health Drug Office | Identifier(s): 60968 |
Country: JP | 医薬品医療機器総合機構 | Identifier(s): 7990103A1029 |
Country: LT | Valstybinė vaistų kontrolės tarnyba | Identifier(s): 1051988, 1065443, 1068149 |
Country: NL | Z-Index G-Standaard, PRK | Identifier(s): 94994 |
Country: NZ | Medicines and Medical Devices Safety Authority | Identifier(s): 21205, 9005 |
Country: RO | Agenția Națională a Medicamentului și a Dispozitivelor Medicale | Identifier(s): W55638001, W55638002, W55638003 |
Country: SG | Health Sciences Authority | Identifier(s): 14303P |
Country: TN | Direction de la Pharmacie et du Médicament | Identifier(s): 16143021 |
Country: TR | İlaç ve Tıbbi Cihaz Kurumu | Identifier(s): 8697621220638 |
Country: ZA | Health Products Regulatory Authority | Identifier(s): A38/11.5/0389 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.